GM-CSF With Post-Transplant Cyclophosphamide
NCT04237623
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
38
Enrollment
OTHER
Sponsor class
Conditions
Transplant-Related Hematologic Malignancy
Interventions
DRUG:
Sargramostim
OTHER:
Control Arm
Sponsor
Northside Hospital, Inc.